Data-handling strategies for metabonomic studies: example of the UHPLC-ESI/ToF urinary signature of tetrahydrocannabinol in humans

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Analytical and Bioanalytical Chemistry

• Publication date

  2014-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00216-013-7199-0PMID 23900670
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuronal metabolomics by ion mobility mass spectrometry: cocaine effects on glucose and selected biogenic amine metabolites in the frontal cortex, striatum, and thalamus of the rat

  2013cited by this paper
• Serum metabolomics as a novel diagnostic approach for disease: a systematic review

  2012cited by this paper
• Metabolomics in toxicology: preclinical and clinical applications.

  2011cited by this paper
• ^1H NMR-based Metabonomic Analysis of Metabolic Changes in Streptozotocin-induced Diabetic Rats

  2010cited by this paper
• Metabolomics: Moving to the Clinic

  2010cited by this paper
• Principal component and hierarchical clustering analysis of metabolites in destructive weeds; polygonaceous plants

  2010cited by this paper
• The evolution of partial least squares models and related chemometric approaches in metabonomics and metabolic phenotyping

  2010cited by this paper
• Metabolome-wide association study identifies multiple biomarkers that discriminate north and south Chinese populations at differing risks of cardiovascular disease: INTERMAP study.

  2010cited by this paper
• Metabolomics of transgenic maize combining Fourier transform-ion cyclotron resonance-mass spectrometry, capillary electrophoresis-mass spectrometry and pressurized liquid extraction.

  2009cited by this paper
• Metabolic profiling of Parkinson's disease: evidence of biomarker from gene expression analysis and rapid neural network detection

  2009cited by this paper
• From differentiating metabolites to biomarkers

  2009cited by this paper
• Development of analytical methods for NMR spectra and application to a 13C toxicology study

  2009cited by this paper
• Metabonomic variations in the drug-treated type 2 diabetes mellitus patients and healthy volunteers.

  2009cited by this paper
• Development of a metabolomic approach based on liquid chromatography-high resolution mass spectrometry to screen for clenbuterol abuse in calves.

  2009cited by this paper
• Metabolomics in pharmaceutical research and development: metabolites, mechanisms and pathways.

  2009cited by this paper
• Advances in separation science applied to metabonomics

  2008cited by this paper
• LC-MS-based metabonomics analysis.

  2008influential reference
• Development and validation of a ultra performance LC-ESI/MS method for analysis of metabolic phenotypes of healthy men in day and night urine samples.

  2008cited by this paper
• Gas chromatography/mass spectrometry in metabolic profiling of biological fluids.

  2008cited by this paper
• Orthogonal projections to latent structures discriminant analysis modeling on in situ FT-IR spectral imaging of liver tissue for identifying sources of variability.

  2008cited by this paper
• Mass spectrometry for the identification of the discriminating signals from metabolomics: current status and future trends.

  2008cited by this paper
• Liquid chromatography and ultra-performance liquid chromatography-mass spectrometry fingerprinting of human urine: sample stability under different handling and storage conditions for metabonomics studies.

  2008cited by this paper
• New technologies around biomarkers and their interplay with drug development

  2008cited by this paper
• Global metabolic profiling analysis on human urine by UPLC-TOFMS: issues and method validation in nutritional metabolomics.

  2008cited by this paper
• UPLC-TOF-MS for plant metabolomics: a sequential approach for wound marker analysis in Arabidopsis thaliana.

  2008cited by this paper
• Visualization and interpretation of OPLS models based on 2D NMR data

  2008cited by this paper
• Metabolomics and biomarker discovery: NMR spectral data of urine and hepatotoxicity by carbon tetrachloride, acetaminophen, and d-galactosamine in rats

  2008cited by this paper
• Proposed minimum reporting standards for chemical analysis

  2007cited by this paper
• Metabonomics in pharmaceutical discovery and development.

  2007influential reference
• Analytical strategies in metabonomics.

  2007cited by this paper
• Tools in metabonomics: an integrated validation approach for LC-MS metabolic profiling of mercapturic acids in human urine.

  2007cited by this paper
• Beyond blood sugar: the potential of NMR-based metabonomics for type 2 human diabetes, and the horse as a possible model

  2007cited by this paper
• Human urine as test material in 1H NMR-based metabonomics: recommendations for sample preparation and storage.

  2007cited by this paper
• Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine.

  2007cited by this paper
• Mass spectrometry-based metabolomics.

  2007cited by this paper
• Validation of a urine metabolome fingerprint in dog for phenotypic classification

  2007cited by this paper
• Metabolic profiling using principal component analysis, discriminant partial least squares, and genetic algorithms.

  2006cited by this paper
• Metabonomics Techniques and Applications to Pharmaceutical Research & Development

  2006cited by this paper
• Scaling and normalization effects in NMR spectroscopic metabonomic data sets.

  2006cited by this paper
• Centering, scaling, and transformations: improving the biological information content of metabolomics data

  2006cited by this paper
• Metabonomics and biomarker discovery: LC-MS metabolic profiling and constant neutral loss scanning combined with multivariate data analysis for mercapturic acid analysis.

  2006cited by this paper
• UvA-DARE ( Digital Academic Repository ) Centering , scaling and transformations : improving the biological information content of metabolomics data

  2006cited by this paper
• Generation of ultrahigh peak capacity LC separations via elevated temperatures and high linear mobile-phase velocities.

  2006cited by this paper
• A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis.

  2006cited by this paper
• Using chemometrics for navigating in the large data sets of genomics, proteomics, and metabonomics (gpm)

  2004cited by this paper
• NMR-based metabonomic toxicity classification: hierarchical cluster analysis and k-nearest-neighbour approaches

  2003influential reference
• Orthogonal projections to latent structures (O‐PLS)

  2002cited by this paper

• Recent trends in application of chemometric methods for GC-MS and GC×GC-MS-based metabolomic studies

  2021cites this paper
• Chemometric and high-resolution mass spectrometry tools for the characterization and comparison of raw and treated wastewater samples of a pilot plant on the SIPIBEL site

  2018cites this paper
• Analytical considerations for (un)-targeted metabolomic studies with special focus on forensic applications.

  2018cites this paper
• Chemometric methods in data processing of mass spectrometry-based metabolomics: A review.

  2016cites this paper
• Comparative analysis of volatile oils in the stems and roots of Ephedra sinica via GC-MS-based plant metabolomics.

  2016cites this paper
• A short review of applications of liquid chromatography mass spectrometry based metabolomics techniques to the analysis of human urine.

  2015cites this paper
• Annual banned-substance review: analytical approaches in human sports drug testing.

  2015cites this paper
• Annual banned-substance review: analytical approaches in human sports drug testing.

  2010cites this paper